BMY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.09%

Insider Buying (Last 12 Months): $200,019.42

Insider Selling (Last 12 Months): $38,934.00

Bristol-Myers Squibb Insider Trading History Chart

Bristol-Myers Squibb Share Price & Price History

^$59.71

▲ +0.908 (1.54%)

As of 02/28/2025 04:59 PM ET

Days: 30 | 90 | 365

Bristol-Myers Squibb Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/14/2025	Samit Hirawat	EVP	Buy	1,823	$54.84	$99,973.32	63,932
11/4/2024	Phil M Holzer	SVP	Sell	700	$55.62	$38,934.00	11,760
11/1/2024	Samit Hirawat	EVP	Buy	1,830	$54.67	$100,046.10	62,109
12/5/2023	Christopher S. Boerner	CEO	Buy	2,000	$49.78	$99,560.00	82,672
11/28/2023	Christopher S. Boerner	CEO	Buy	3,071	$48.86	$150,049.06	79,384
11/20/2023	Theodore R. Samuels, II	Director	Buy	8,500	$49.81	$423,385.00	35,500
8/24/2023	Ann Powell	EVP	Sell	17,986	$61.25	$1,101,642.50	27,868
8/3/2023	Robert M. Plenge	EVP	Sell	732	$61.14	$44,754.48	6,584
5/3/2023	Rupert Vessey	EVP	Sell	50,385	$67.06	$3,378,818.10	47,751
2/6/2023	Ann Powell	EVP	Sell	11,183	$74.69	$835,258.27	23,043
2/6/2023	Giovanni Caforio	CEO	Sell	240,000	$74.65	$17,916,000.00	236,104
11/9/2022	Ann Powell	EVP	Sell	16,250	$80.45	$1,307,312.50	34,226
11/7/2022	Rupert Vessey	EVP	Sell	45,910	$78.88	$3,621,380.80	57,079
9/20/2022	Giovanni Caforio	CEO	Sell	25,000	$69.71	$1,742,750.00	476,104
9/15/2022	Giovanni Caforio	CEO	Sell	50,000	$71.84	$3,592,000.00	501,104
9/14/2022	Ann Powell	EVP	Sell	25,000	$70.75	$1,768,750.00	50,476
9/13/2022	David V. Elkins	CFO	Sell	133,951	$71.30	$9,550,706.30	100,460
6/13/2022	Giovanni Caforio	CEO	Sell	30,000	$74.04	$2,221,200.00	551,104
6/6/2022	Sandra Leung	EVP	Sell	65,000	$74.89	$4,867,850.00	308,627
3/21/2022	Giovanni Caforio	CEO	Sell	25,000	$71.52	$1,788,000.00
3/16/2022	Rupert Vessey	EVP	Sell	74,559	$69.25	$5,163,210.75
3/14/2022	Christopher S. Boerner	EVP	Sell	29,532	$69.20	$2,043,614.40
3/14/2022	Karen Murphy Santiago	SVP	Sell	6,577	$69.19	$455,062.63

See Full Table

SEC Filings (Institutional Ownership Changes) for Bristol-Myers Squibb (NYSE:BMY)

76.41% of Bristol-Myers Squibb stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bristol-Myers Squibb Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2025	Park Square Financial Group LLC	459	$26K	0.0%	N/A	0.000%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	1,764,114	$99.78M	0.2%	N/A	0.087%
2/28/2025	Employees Retirement System of Texas	41,042	$2.32M	0.0%	-27.5%	0.002%
2/27/2025	Pinnacle Wealth Planning Services Inc.	4,514	$0.26M	0.0%	+8.4%	0.000%
2/25/2025	Heck Capital Advisors LLC	3,331	$0.19M	0.0%	N/A	0.000%
2/25/2025	Leigh Baldwin & CO. LLC	9,443	$0.53M	0.3%	N/A	0.000%
2/25/2025	B. Riley Wealth Advisors Inc.	147,366	$8.34M	0.3%	-3.8%	0.007%
2/25/2025	Shufro Rose & Co. LLC	8,560	$0.48M	0.0%	-5.0%	0.000%
2/25/2025	Integrated Advisors Network LLC	17,388	$0.98M	0.0%	-8.2%	0.001%
2/25/2025	Polar Asset Management Partners Inc.	294,400	$16.65M	0.2%	N/A	0.015%
2/24/2025	Hall Capital Management Co. Inc.	5,815	$0.33M	0.2%	N/A	0.000%
2/24/2025	Great Valley Advisor Group Inc.	34,203	$1.93M	0.0%	-2.2%	0.002%
2/24/2025	Ameriflex Group Inc.	5,463	$0.32M	0.1%	N/A	0.000%
2/24/2025	United Advisor Group LLC	20,391	$1.15M	0.2%	-4.7%	0.001%
2/21/2025	Ascent Group LLC	44,469	$2.52M	0.2%	+37.9%	0.002%
2/21/2025	WNY Asset Management LLC	5,452	$0.31M	0.0%	-32.5%	0.000%
2/21/2025	Aurdan Capital Management LLC	10,000	$0.57M	0.2%	N/A	0.000%
2/21/2025	Vermillion Wealth Management Inc.	991	$56K	0.0%	N/A	0.000%
2/21/2025	AlphaCore Capital LLC	18,682	$1.06M	0.2%	-3.0%	0.001%
2/20/2025	Mackenzie Financial Corp	585,766	$33.13M	0.0%	+84.2%	0.029%
2/20/2025	Forum Financial Management LP	16,884	$0.96M	0.0%	+47.8%	0.001%
2/19/2025	Formidable Asset Management LLC	10,652	$0.60M	0.1%	-2.3%	0.001%
2/19/2025	North Star Asset Management Inc.	12,025	$0.68M	0.0%	+68.1%	0.001%
2/19/2025	GF Fund Management CO. LTD.	49,748	$2.81M	0.1%	N/A	0.002%
2/19/2025	Twin Lakes Capital Management LLC	5,046	$0.29M	0.2%	-13.1%	0.000%
2/19/2025	Pinney & Scofield Inc.	450	$25K	0.0%	N/A	0.000%
2/19/2025	Parr Mcknight Wealth Management Group LLC	5,539	$0.31M	0.0%	N/A	0.000%
2/19/2025	Public Employees Retirement System of Ohio	897,664	$50.77M	0.2%	-19.1%	0.044%
2/18/2025	Pacific Point Advisors LLC	9,802	$0.58M	0.4%	N/A	0.000%
2/18/2025	GTS Securities LLC	19,911	$1.13M	0.1%	-127.9%	0.001%
2/18/2025	Fourth Dimension Wealth LLC	846	$48K	0.0%	N/A	0.000%
2/18/2025	Vise Technologies Inc.	44,870	$2.54M	0.2%	+34.9%	0.002%
2/18/2025	Headinvest LLC	16,046	$0.91M	0.2%	-12.5%	0.001%
2/18/2025	JT Stratford LLC	33,554	$1.90M	0.3%	+215.8%	0.002%
2/18/2025	Cornerstone Advisory LLC	7,495	$0.40M	0.0%	+12.8%	0.000%
2/18/2025	Inspire Trust Co. N.A.	58,000	$3.28M	0.8%	-44.0%	0.003%
2/18/2025	Orion Capital Management LLC	1,550	$88K	0.0%	N/A	0.000%
2/18/2025	Novem Group	3,626	$0.21M	0.0%	N/A	0.000%
2/18/2025	10Elms LLP	1,514	$86K	0.1%	N/A	0.000%
2/18/2025	MidWestOne Financial Group Inc.	27,060	$1.53M	0.2%	-2.7%	0.001%
2/18/2025	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	388,228	$21.96M	0.1%	+14.8%	0.019%
2/18/2025	Focus Partners Advisor Solutions LLC	27,054	$1.53M	0.0%	-39.1%	0.001%
2/18/2025	CSS LLC IL	31,940	$1.81M	0.1%	+19.9%	0.002%
2/18/2025	Kolinsky Wealth Management LLC	3,609	$0.20M	0.1%	N/A	0.000%
2/18/2025	Continuum Advisory LLC	1,733	$98K	0.0%	+15.1%	0.000%
2/18/2025	NCM Capital Management LLC	21,626	$1.22M	0.6%	+1.1%	0.001%
2/18/2025	White Knight Strategic Wealth Advisors LLC	4,376	$0.25M	0.1%	-37.0%	0.000%
2/18/2025	Principal Street Partners LLC	120,268	$6.80M	1.3%	+1.7%	0.006%
2/18/2025	Lantern Wealth Advisors LLC	26,032	$1.47M	1.0%	+77.3%	0.001%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	22,271,742	$1.26B	0.3%	+16.8%	1.098%
2/17/2025	USS Investment Management Ltd	353,836	$20.03M	0.1%	-11.7%	0.017%
2/17/2025	Waverly Advisors LLC	32,099	$1.82M	0.0%	+140.0%	0.002%
2/17/2025	Wallace Capital Management Inc.	3,650	$0.21M	0.0%	N/A	0.000%
2/17/2025	Wesleyan Assurance Society	59,492	$3.37M	0.3%	-14.2%	0.003%
2/17/2025	William B. Walkup & Associates Inc.	4,581	$0.26M	0.2%	+9.6%	0.000%
2/17/2025	Williams Jones Wealth Management LLC.	12,320	$0.70M	0.0%	-22.0%	0.001%
2/17/2025	Woodline Partners LP	1,561,622	$88.33M	0.6%	+100.7%	0.077%
2/17/2025	Zimmer Partners LP	378,000	$21.38M	0.4%	N/A	0.019%
2/17/2025	Zurich Insurance Group Ltd FI	482,604	$27.30M	0.2%	+707.0%	0.024%
2/17/2025	Vident Advisory LLC	74,513	$4.22M	0.1%	-4.3%	0.004%
2/17/2025	Westwood Holdings Group Inc.	25,191	$1.43M	0.0%	+397.2%	0.001%
2/17/2025	St. Clair Advisors LLC	6,000	$0.34M	0.1%	N/A	0.000%
2/17/2025	Triglav Skladi D.O.O.	28,900	$1.64M	0.1%	N/A	0.001%
2/17/2025	Trustco Bank Corp N Y	6,173	$0.35M	0.4%	-12.7%	0.000%
2/17/2025	Two Sigma Investments LP	85,624	$4.84M	0.0%	-98.2%	0.004%
2/17/2025	Two Sigma Advisers LP	1,857,900	$105.08M	0.2%	-80.5%	0.092%
2/17/2025	Texas Bank & Trust Co	13,215	$0.75M	0.3%	N/A	0.001%
2/17/2025	Tidal Investments LLC	90,197	$5.10M	0.0%	-28.0%	0.004%
2/17/2025	TrinityPoint Wealth LLC	7,948	$0.45M	0.1%	+21.3%	0.000%
2/17/2025	Trace Wealth Advisors LLC	7,342	$0.42M	0.4%	N/A	0.000%
2/17/2025	State of Wyoming	7,987	$0.45M	0.1%	+317.5%	0.000%
2/17/2025	Stonebrook Private Inc.	15,146	$0.86M	0.2%	+1.9%	0.001%
2/17/2025	Strategic Global Advisors LLC	100,816	$5.70M	1.0%	+4.3%	0.005%
2/17/2025	Strategic Wealth Partners Ltd.	4,994	$0.28M	0.0%	-4.1%	0.000%
2/17/2025	Thornburg Investment Management Inc.	38,400	$2.17M	0.0%	-44.5%	0.002%
2/17/2025	Toronto Dominion Bank	1,145,990	$64.82M	0.1%	+37.2%	0.057%
2/17/2025	Stempoint Capital LP	166,068	$9.39M	2.3%	-39.7%	0.008%
2/17/2025	Suvretta Capital Management LLC	33,800	$1.91M	0.1%	N/A	0.002%
2/17/2025	Second Line Capital LLC	3,539	$0.20M	0.1%	-35.5%	0.000%
2/17/2025	Snowden Capital Advisors LLC	69,058	$3.91M	0.1%	-34.1%	0.003%
2/17/2025	Siemens Fonds Invest GmbH	24,994	$1.41M	0.1%	-64.0%	0.001%
2/17/2025	Shell Asset Management Co.	64,402	$3.64M	0.2%	-6.5%	0.003%
2/17/2025	Sphera Funds Management LTD.	20,000	$1.13M	0.2%	N/A	0.001%
2/17/2025	Rafferty Asset Management LLC	236,274	$13.36M	0.0%	+10.1%	0.012%
2/17/2025	Raiffeisen Bank International AG	367,240	$20.61M	0.3%	N/A	0.018%
2/17/2025	Redwood Investment Management LLC	42,509	$2.40M	0.2%	-69.9%	0.002%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	81,262	$4.60M	1.2%	+236.1%	0.004%
2/17/2025	Point72 Europe London LLP	218,813	$12.38M	0.7%	+291.8%	0.011%
2/17/2025	Point72 Hong Kong Ltd	270,478	$15.30M	0.9%	+1,012.5%	0.013%
2/17/2025	Polar Asset Management Partners Inc.	294,400	$16.65M	0.2%	N/A	0.015%
2/17/2025	ProShare Advisors LLC	345,959	$19.57M	0.0%	+9.3%	0.017%
2/17/2025	Quadcap Wealth Management LLC	19,585	$1.11M	0.2%	+41.5%	0.001%
2/17/2025	Quantinno Capital Management LP	252,908	$14.31M	0.1%	+27.2%	0.012%
2/17/2025	Pathstone Holdings LLC	210,867	$11.93M	0.1%	+11.6%	0.010%
2/17/2025	Mufg Securities Americas Inc.	29,939	$1.69M	0.2%	N/A	0.001%
2/17/2025	Man Group plc	1,728,127	$97.74M	0.3%	-46.5%	0.085%
2/17/2025	Nissay Asset Management Corp Japan ADV	257,222	$14.84M	0.1%	-1.9%	0.013%
2/17/2025	Nan Shan Life Insurance Co. Ltd.	943,596	$53.37M	1.3%	-26.4%	0.047%
2/17/2025	Nearwater Capital Markets Ltd	280,000	$15.84M	0.5%	N/A	0.014%
2/17/2025	NorthRock Partners LLC	26,839	$1.52M	0.0%	+192.8%	0.001%

Data available starting January 2016

See Full Table

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $59.71

$57.92

$59.74

50 Day Range

MA: $57.15

$53.85

$60.61

52 Week Range

Now: $59.71

$39.35

$61.10

Volume

20,217,502 shs

Average Volume

11,179,307 shs

Market Capitalization

$121.17 billion

P/E Ratio

N/A

Dividend Yield

4.28%

Beta

0.45

Who are the company insiders with the largest holdings of Bristol-Myers Squibb?: Bristol-Myers Squibb's top insider shareholders include:
Christopher S Boerner (CEO)
Samit Hirawat (EVP)
Rupert Vessey (EVP)
Theodore R Samuels II (Director)
Ann Powell (EVP)
Phil M Holzer (SVP)
Robert M Plenge (EVP)
Learn More about top insider investors at Bristol-Myers Squibb.
Who are the major institutional investors of Bristol-Myers Squibb?: Bristol-Myers Squibb's top institutional shareholders include:
Vanguard Group Inc. — 9.37%
Charles Schwab Investment Management Inc. — 2.97%
Capital International Investors — 2.26%
Geode Capital Management LLC — 2.19%
Norges Bank — 1.73%
Ameriprise Financial Inc. — 1.58%
Learn More about top institutional investors of Bristol-Myers Squibb stock.
Which institutional investors are selling Bristol-Myers Squibb stock?: During the last quarter, BMY stock was sold by these institutional investors:
FMR LLC
Price T Rowe Associates Inc. MD
Two Sigma Advisers LP
Two Sigma Investments LP
Legal & General Group Plc
Susquehanna International Group LLP
Amundi
Citadel Advisors LLC
Which institutional investors are buying Bristol-Myers Squibb stock?: Within the previous quarter, BMY stock was acquired by institutional investors including:
Norges Bank
Ameriprise Financial Inc.
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main
Wellington Management Group LLP
Raymond James Financial Inc.
Schroder Investment Management Group
Northern Trust Corp
Adage Capital Partners GP L.L.C.
During the last year, these company insiders have bought Bristol-Myers Squibb stock:
Christopher S Boerner (CEO)
Samit Hirawat (EVP)
Rupert Vessey (EVP)
Learn More investors buying Bristol-Myers Squibb stock.